Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TTK HealthcareBOM:507747 -1.34%72 Days Payable is 78.44 as of Mar. 2026, which is 30% below its 10-year median of 111.47. GuruFocus rates BOM:507747 with a GF Score™ of 72/100 and a GF Value™ of ₹1,455.53 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 927 Drug Manufacturers companies, TTK Healthcare ranks worse than 50.7% on this metric.
The historical rank and industry rank for TTK Healthcare's Days Payable or its related term are showing as below:
BOM:507747'
s Days Payable Range Over the Past 10 Years
Min: 89.01 Med: 111.47 Max: 158.81
Current: 89.39
During the past 13 years, TTK Healthcare's highest Days Payable was 158.81. The lowest was 89.01. And the median was 111.47.
BOM:507747's Days Payable is ranked worse than 50.7% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs BOM:507747: 89.39
TTK Healthcare's Days Payable
declined
from Mar. 2025 (111.41) to Mar. 2026 (78.44).
It may suggest that TTK Healthcareaccelerated paying its suppliers.
TTK Healthcare Days Payable Related Terms
TTK Healthcare Days Payable Historical Data
* Premium members only.
The historical data trend for TTK Healthcare's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:507747 vs LLY, JNJ, ABBV: Days Payable Comparison
For the Drug Manufacturers - General subindustry, TTK Healthcare's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TTK Healthcare Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, TTK Healthcare's Days Payable distribution charts can be found below:
* The bar in red indicates where TTK Healthcare's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
TTK Healthcare's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TTK Healthcare (BOM:507747) has a Days Payable of 78.44 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on TTK Healthcare and its competitors. This is 30% below median its historical median of 111.47. Over the past decade, TTK Healthcare's Days Payable has ranged from 89.01 to 158.81. According to the industry distribution chart, TTK Healthcare ranks #470 out of 927 companies in the Drug Manufacturers industry, placing it in the top 50.7%.
Is TTK Healthcare's Days Payable too high?
TTK Healthcare's current Days Payable of 78.44 is 30% below median its 10-year median of 111.47. Over the past 10 years, this metric has ranged from a low of 89.01 to a high of 158.81. The Drug Manufacturers industry median Days Payable is 90.38. TTK Healthcare's value of 78.44 is 13.2% below this industry median. Based on the distribution chart, TTK Healthcare ranks #470 out of 927 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, TTK Healthcare has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TTK Healthcare's Days Payable compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, TTK Healthcare ranks #470 out of 927 companies for Days Payable. This places TTK Healthcare in the lower half of its industry. The industry median Days Payable is 90.38. TTK Healthcare's value of 78.44 is 13.2% below this benchmark. Historically, TTK Healthcare's own Days Payable has ranged from 89.01 to 158.81 over the past decade. While the company's 10-year median is 111.47 vs. the industry median of 90.38, TTK Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TTK Healthcare's current Days Payable of 78.44 is 13.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on TTK Healthcare and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TTK Healthcare's current Days Payable is 78.44, which is 30% below median its own 10-year median of 111.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TTK Healthcare stock overvalued right now?
Based on GuruFocus' analysis, TTK Healthcare (BOM:507747) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹1,455.53, compared to a current price of ₹987.45 — trading 32.2% below its estimated fair value. The current Days Payable is 78.44, which is 30% below median its 10-year median of 111.47 and 13.2% below the Drug Manufacturers industry median of 90.38. TTK Healthcare's overall GF Score™ is 72/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For TTK Healthcare (BOM:507747), the current Days Payable is 78.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TTK Healthcare (BOM:507747) Overvalued in 2026?
Based on GuruFocus' analysis, TTK Healthcare stock appears to be undervalued.
The current stock price of ₹987.45 is trading 32.2% below its estimated GF Value™ of ₹1,455.53.
GuruFocus considers TTK Healthcare to be Significantly Undervalued.
Key valuation signals for BOM:507747:
Days Payable: 78.44 (30% below median its 10-year median of 111.47)
GF Value™: ₹1,455.53 vs. price of ₹987.45 (32.2% below fair value)
Industry Position: 13.2% below the Drug Manufacturers median (#470 of 927)
No single metric tells the full story. See the BOM:507747 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TTK Healthcare Ltd is an Indian pharmaceutical company. The company's operating segment includes Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods Division, and Others. Its Animal Welfare segment includes products for both Human and Veterinary use. The Consumer Products comprises of marketing and distribution of Woodwards's Gripe Water, EVA Range of Cosmetics, Good Home range of Scrubbers, Air Fresheners and others. Protective Devices comprises of manufacturing and marketing of Male Contraceptives and other allied products. It generates maximum revenue from the Pharmaceuticals segment. Geographically, it derives a majority of revenue from India.
72GF Score
Get the complete analysis for BOM:507747
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:507747 has been successfully added to your 
